. Pre-treatment with specific p38 inhibitor reverses PMC-A mediated Bcl-2 downregulation. HCT116 wt cells were pretreated with indicated concentrations of JNK (SP600125), p38 MAPK (SB203580) or IKK inhibitors for 30 min, treated with 50 M PMC-A, collected at 4h (Bax/Bim) or 24h (Bcl-2), lysed and immunoblotted using anti-Bax, anti-Bim, anti-Bcl-2 and anti--actin antibodies. -actin was used as loading control. Results from one of three independent experiments are shown. PMC-A induced depletion of cellular Bcl-2 was restored upon pharmacological inhibition of p38MAPK in a dose-dependent manner. PMC-A induced Bim/Bax elevation was not affected with any of the three inhibitors used.
